| Trial ID: | L0977 |
| Source ID: | NCT00633282
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Role of Pioglitazone and Berberine in Treatment of Non-alcoholic Fatty Liver Disease(NAFLD) Patients With Impaired Glucose Regulation or Type 2 Diabetes Mellitus
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Behavioral: Life style intervention;Drug: pioglitazone;Drug: berberine
|
| Outcome Measures: |
Improved metabolic parameters(glucose, lipid, liver enzymes, etc.)liver fat content;serum insulin;the ratio of withdrawing because of inefficiency
|
| Sponsor/Collaborators: |
Xin Gao
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
184
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
| Start Date: |
03/03/2008
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
China
|
| URL: |
http://clinicaltrials.gov/show/NCT00633282
|
